AVH News: AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients - 17th Jun 2023, 4:47am

annb0t

Top 20
AVITA Medical

VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has approved its application for premarket approval (PMA) of its RECELL® System for the treatment of vitiligo.

RECELL for repigmentat...

>>> Read more: AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients
 
  • Like
Reactions: 1 users
Top Bottom